GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sanai Health Industry Group Co 1889.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.18

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Sanai Health Industry Group Co

Its shares trade on HKEX under the ticker 1889.HK. It has been listed since 21 March 2006. In the fiscal year to 31 December 2025, it reported revenue of CN¥85.9m and a net loss of CN¥22.0m. At that date it held total assets of CN¥421.7m and shareholders' equity of CN¥298.3m.

Sanai Health Industry Group Co. Ltd. is an investment holding company, which through its subsidiaries, engages in developing, manufacturing, marketing, and sales of pharmaceutical products. The company employs 71 full-time employees The company went IPO on 2006-03-21. The firm operates its business through three segments. The Pharmaceutical Products segment mainly engages in the development, manufacturing, marketing and sales of pharmaceutical products, sales of pharmaceutical related software and provision of consultancy services. The Finance Leasing segment mainly engages in the provision of finance leasing services. The Other General Trading segment engages in the distribution of fitness equipment, electric appliances and other goods for general trading.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
21 Mar 2006
Employees
71
Website
1889hk.com ↗

Leadership

Pay as last reported

  • Mr. Cheng Qing ChenExecutive Director, since 2017CN¥199,000
  • Mr. Hao SheExecutive Director, since 2019CN¥199,000
  • Mr. Haijing XieExecutive Director, since 2024
  • Mr. Chaoyang YuanExecutive Director, since 2019CN¥199,000
  • Prof. Rongqing ZhangExecutive Director, since 2017CN¥100,000
  • Ms. Yuen Fong ChanCompany Secretary
  • Mr. Khie Liem KhorIndependent Non-Executive DirectorCN¥136,000
  • Ms. Yuen Tan TsuiNon-Executive Independent Director
  • Prof. Yi Zhun ZhuIndependent Non-Executive DirectorCN¥100,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company employs 71 full-time employees
  • Operates through three business segments including pharmaceuticals, finance leasing, and general trading
  • Has a public listing with ticker 1889.HK and ISIN KYG7785S1158

Weaknesses

  • City location is unknown
  • Source description treats facts as untrusted
  • IPO date is 2006-03-21 which may indicate limited market presence

Opportunities

  • Expanding pharmaceutical segment through development and manufacturing
  • Potential growth in finance leasing segment services
  • Diversification through other general trading activities

Threats

  • Untrusted source description may affect credibility
  • Limited market presence due to IPO date in 2006
  • Unknown city location may hinder operational clarity

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.